Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06007872 · ClinicalTrials.gov registry record · NA
Intracardiac Echocardiography Guided Watchman Device Implant
A NA study of Atrial Fibrillation and Left Atrial Appendage Thrombosis, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06007872: Recruiting NA study of Atrial Fibrillation and Left Atrial Appendage Thrombosis, sponsored by The Cleveland Clinic.
NCT06007872 is a NA study of Atrial Fibrillation and Left Atrial Appendage Thrombosis that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 100 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06007872, a NA study of Atrial Fibrillation and Left Atrial Appendage Thrombosis, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to look at the success of Intracardiac Echocardiography (ICE) in the Watchman procedure. Currently the process is to use a Transesophageal Echocardiography (TEE) to place the Watchman in patients. This study is aiming to show how the ICE is just as effective in placing the device correctly and effectively.
Primary Outcome
Intracardiac echocardiography (ICE) guided Watchman placement confirmed by transesophageal echocardiography (TEE)
Conditions Studied
Interventions
- DEVICE Intracardiac Echocardiography (ICE)
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-12-02 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT06007872 shows while recruiting
NCT06007872 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Intracardiac Echocardiography (ICE) is the first listed.
NCT06007872 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06007872 about?
NCT06007872 is a clinical study titled "Intracardiac Echocardiography Guided Watchman Device Implant". This study is to look at the success of Intracardiac Echocardiography (ICE) in the Watchman procedure. Currently the process is to use a Transesophageal Echocardiography (TEE) to place the Watchman in patients. This study is aiming to show how the ICE is just as effective in placing the device corre...
What is the current status of trial NCT06007872?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-12-02. Estimated completion is 2027-12-31.
What conditions does trial NCT06007872 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Left Atrial Appendage Thrombosis.
What interventions are being tested in trial NCT06007872?
The interventions under investigation include: Intracardiac Echocardiography (ICE) (DEVICE).
Who is sponsoring clinical trial NCT06007872?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06007872 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06007872's enrollment target sits among peer trials
100 139th of 202 higher than 59 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI